Back to UBS Group AG UBS Group AG

RVNCRVNC
Showing 3 of 25 quarters

Position history for UBS Group AGUBS Group AG's holdings in REVANCE THERAPEUTICS INC

UBS Group AG previously held 0 shares of RVNC (REVANCE THERAPEUTICS INC), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$3.3M

Total Shares Change

-632,553

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%
0
2024-Q4
Increased
1.5M
+134.4%
$4.5M0.0%
43
2024-Q3
Increased
632,553
+1145.8%
$3.3M0.0%
43

Other major holders of RVNC: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used